202 related articles for article (PubMed ID: 32095915)
1. Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.
Silva AI; Holanda VAD; Azevedo Neto JG; Silva Junior ED; Soares-Rachetti VP; Calo G; Ruzza C; Gavioli EC
Psychopharmacology (Berl); 2020 Jun; 237(6):1633-1642. PubMed ID: 32095915
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the NOP receptor signaling affects resilience to acute stress.
Holanda VAD; Pacifico S; Azevedo Neto J; Finetti L; Lobão-Soares B; Calo G; Gavioli EC; Ruzza C
J Psychopharmacol; 2019 Dec; 33(12):1540-1549. PubMed ID: 31337258
[TBL] [Abstract][Full Text] [Related]
3. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
Asth L; Ruzza C; Malfacini D; Medeiros I; Guerrini R; Zaveri NT; Gavioli EC; Calo' G
Neuropharmacology; 2016 Jun; 105():434-442. PubMed ID: 26867504
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness.
Holanda VA; Medeiros IU; Asth L; Guerrini R; Calo' G; Gavioli EC
Psychopharmacology (Berl); 2016 Jul; 233(13):2525-32. PubMed ID: 27129865
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.
Gavioli EC; Calo' G
Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):319-30. PubMed ID: 16491387
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test.
Silva EF; Silva AI; Asth L; Souza LS; Zaveri NT; Guerrini R; Calo' G; Ruzza C; Gavioli EC
Behav Brain Res; 2019 Jan; 356():120-126. PubMed ID: 30142397
[TBL] [Abstract][Full Text] [Related]
7. NOP Ligands for the Treatment of Anxiety and Mood Disorders.
Gavioli EC; Holanda VAD; Ruzza C
Handb Exp Pharmacol; 2019; 254():233-257. PubMed ID: 30535941
[TBL] [Abstract][Full Text] [Related]
8. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
9. Fear expression is reduced after acute and repeated nociceptin/orphanin FQ (NOP) receptor antagonism in rats: therapeutic implications for traumatic stress exposure.
Taylor RM; Jeong IH; May MD; Bergman EM; Capaldi VF; Moore NLT; Matson LM; Lowery-Gionta EG
Psychopharmacology (Berl); 2020 Oct; 237(10):2943-2958. PubMed ID: 32588078
[TBL] [Abstract][Full Text] [Related]
10. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
Gavioli EC; Calo' G
Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
[TBL] [Abstract][Full Text] [Related]
11. Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice.
Medeiros IU; Ruzza C; Asth L; Guerrini R; Romão PR; Gavioli EC; Calo G
Peptides; 2015 Oct; 72():95-103. PubMed ID: 26028163
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies.
Rizzi A; Gavioli EC; Marzola G; Spagnolo B; Zucchini S; Ciccocioppo R; Trapella C; Regoli D; Calò G
J Pharmacol Exp Ther; 2007 Jun; 321(3):968-74. PubMed ID: 17329551
[TBL] [Abstract][Full Text] [Related]
13. Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.
Goeldner C; Spooren W; Wichmann J; Prinssen EP
Psychopharmacology (Berl); 2012 Jul; 222(2):203-14. PubMed ID: 22249359
[TBL] [Abstract][Full Text] [Related]
14. Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling.
Holanda VAD; de Almeida RN; de Oliveira MC; da Silva Junior ED; Galvão-Coelho NL; Calo' G; Ruzza C; Gavioli EC
Psychopharmacology (Berl); 2024 May; 241(5):1001-1010. PubMed ID: 38270614
[TBL] [Abstract][Full Text] [Related]
15. Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test.
Gavioli EC; Marzola G; Guerrini R; Bertorelli R; Zucchini S; De Lima TC; Rae GA; Salvadori S; Regoli D; Calo G
Eur J Neurosci; 2003 May; 17(9):1987-90. PubMed ID: 12752799
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
[TBL] [Abstract][Full Text] [Related]
17. The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus.
D'Oliveira da Silva F; Azevedo Neto J; Sturaro C; Guarino A; Robert C; Gavioli EC; Calo G; Mouledous L; Ruzza C
Neuropharmacology; 2022 Jul; 212():109077. PubMed ID: 35513173
[TBL] [Abstract][Full Text] [Related]
18. NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine.
Holanda VAD; Santos WB; Asth L; Guerrini R; Calo' G; Ruzza C; Gavioli EC
Psychopharmacology (Berl); 2018 Nov; 235(11):3093-3102. PubMed ID: 30145654
[TBL] [Abstract][Full Text] [Related]
19. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
Zhang Y; Simpson-Durand CD; Standifer KM
Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
[TBL] [Abstract][Full Text] [Related]
20. Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eating.
Hardaway JA; Jensen J; Kim M; Mazzone CM; Sugam JA; Diberto JF; Lowery-Gionta EG; Hwa LS; Pleil KE; Bulik CM; Kash TL
Behav Brain Res; 2016 Jul; 307():25-34. PubMed ID: 27036650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
